{
    "abstract": "Emerging evidence suggests seeding and prion-like propagation of mutant Superoxide Dismutase 1 (SOD1) misfolding to be a potential mechanism for ALS pathogenesis and progression. Immuno-targeting of misfolded SOD1 has shown positive clinical outcomes in mutant SOD1 transgenic mice. However, a major challenge in developing active immunotherapies for proteinopathies such as ALS is the design of immunogens enabling exclusive recognition of pathogenic species of a self-protein. Ideally, one would achieve a robust antibody response against the disease-misfolded protein while sparing the natively folded conformer to avoid inducing deleterious autoimmune complications, or inhibiting its normal function. Using a motor neuron disease mouse model expressing human SOD1-G37R, we herein report the immunogenicity and therapeutic efficacy of two ALS vaccines, tgG-DSE2lim and tgG-DSE5b, based on the notion that native SOD1 would undergo early unfolding in disease to present \u201cdisease specific epitopes\u201d (DSE). Both vaccines elicited rapid, robust, and well-sustained epitope-specific antibody responses with a desirable Th2-biased immune response. Both vaccines significantly extended the life expectancy of hSOD1G37R mice, with tgG-DSE2lim displaying greater protection than tgG-DSE5b at earlier pre-symptomatic stage. tgG-DSE5b, but not tgG-DSE2lim, significantly delayed disease onset and appreciably slowed disease progression. This implies that conformationally distinct species of misfolded SOD1 may derive from the same mutation, thereby modifying disease phenotypes in a different fashion. Our results validate the rationale for conformation-based immuno-targeting of misfolded SOD1 as a promising therapeutic strategy to slow or even halt disease progression in familial ALS associated with SOD1 mutations, as well as a prophylactic intervention for carriers of SOD1 mutations. Our study not only provides important proof-of-principle data for the development of a safe and effective human therapeutic/prophylactic ALS vaccine against misfolded SOD1, but also predicts a great potential to extend our DSE-based vaccination approach to other types of ALS, such as those associated with TDP-43 proteinopathies.",
    "author_highlights": [
        {
            "endOffset": 12292,
            "sentence": "Generation of two conformation-based vaccines directed against disease-specific epitopes of misfolded SOD1.",
            "startOffset": 12185
        },
        {
            "endOffset": 12412,
            "sentence": "Both vaccines elicit robust, sustained, and desirable Th2-biased epitope-specific antibody responses in immunized mice.",
            "startOffset": 12293
        },
        {
            "endOffset": 12523,
            "sentence": "Both vaccines significantly ameliorate disease phenotypes in a transgenic mouse model of motor neuron disease.",
            "startOffset": 12413
        },
        {
            "endOffset": 12635,
            "sentence": "Potential development of a conformation-based multivalent vaccine targeting distinct species of misfolded SOD1.",
            "startOffset": 12524
        },
        {
            "endOffset": 12731,
            "sentence": "Potential application of our vaccination strategy to other proteinopathies associated with ALS.",
            "startOffset": 12636
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Leslie I.",
                    "initial": "L.I.",
                    "last": "Grad"
                },
                {
                    "first": "Guy A.",
                    "initial": "G.A.",
                    "last": "Rouleau"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Ravits"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                }
            ],
            "doi": "10.1101/cshperspect.a024117",
            "issn": "21571422",
            "pmid": "28003278",
            "pub_year": 2017,
            "title": "Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)",
            "volume": "7"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Robert G.",
                    "initial": "R.G.",
                    "last": "Miller"
                },
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "Mitchell"
                },
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Moore"
                }
            ],
            "firstpage": "CD001447",
            "issn": "1469493X",
            "pmid": "22419278",
            "pub_year": 2012,
            "title": "Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).",
            "volume": "3"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Michael A.",
                    "initial": "M.A.",
                    "last": "Hough"
                },
                {
                    "first": "J. G\u00fcnter",
                    "initial": "J.G.",
                    "last": "Grossmann"
                },
                {
                    "first": "Svetlana V.",
                    "initial": "S.V.",
                    "last": "Antonyuk"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Strange"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Doucette"
                },
                {
                    "first": "Jorge A.",
                    "initial": "J.A.",
                    "last": "Rodriguez"
                },
                {
                    "first": "Lisa J.",
                    "initial": "L.J.",
                    "last": "Whitson"
                },
                {
                    "first": "P. John",
                    "initial": "P.J.",
                    "last": "Hart"
                },
                {
                    "first": "Lawrence J.",
                    "initial": "L.J.",
                    "last": "Hayward"
                },
                {
                    "first": "Joan Selverstone",
                    "initial": "J.S.",
                    "last": "Valentine"
                },
                {
                    "first": "S. Samar",
                    "initial": "S.S.",
                    "last": "Hasnain"
                }
            ],
            "doi": "10.1073/pnas.0305143101",
            "firstpage": "5976",
            "issn": "00278424",
            "lastpage": "5981",
            "pmid": "15056757",
            "pub_year": 2004,
            "title": "Dimer destabilization in superoxide dismutase may result in disease-causing properties: Structures of motor neuron disease mutants",
            "volume": "101"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Rishi",
                    "initial": "R.",
                    "last": "Rakhit"
                },
                {
                    "first": "Avijit",
                    "initial": "A.",
                    "last": "Chakrabartty"
                }
            ],
            "doi": "10.1016/j.bbadis.2006.05.004",
            "firstpage": "1025",
            "issn": "09254439",
            "lastpage": "1037",
            "pmid": "16814528",
            "pub_year": 2006,
            "title": "Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis",
            "volume": "1762"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Joan Selverstone",
                    "initial": "J.S.",
                    "last": "Valentine"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Doucette"
                },
                {
                    "first": "Soshanna Zittin",
                    "initial": "S.Z.",
                    "last": "Potter"
                }
            ],
            "doi": "10.1146/annurev.biochem.72.121801.161647",
            "firstpage": "563",
            "issn": "00664154",
            "lastpage": "593",
            "pmid": "15952898",
            "pub_year": 2005,
            "title": "Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis",
            "volume": "74"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Daniel R.",
                    "initial": "D.R.",
                    "last": "Rosen"
                },
                {
                    "first": "Teepu",
                    "initial": "T.",
                    "last": "Siddique"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Patterson"
                },
                {
                    "first": "Denise A.",
                    "initial": "D.A.",
                    "last": "Figlewicz"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Sapp"
                },
                {
                    "first": "Afif",
                    "initial": "A.",
                    "last": "Hentati"
                },
                {
                    "first": "Deirdre",
                    "initial": "D.",
                    "last": "Donaldson"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Goto"
                },
                {
                    "first": "Jeremiah P.",
                    "initial": "J.P.",
                    "last": "O'Regan"
                },
                {
                    "first": "Han Xiang",
                    "initial": "H.X.",
                    "last": "Deng"
                },
                {
                    "first": "Zohra",
                    "initial": "Z.",
                    "last": "Rahmani"
                },
                {
                    "first": "Aldis",
                    "initial": "A.",
                    "last": "Krizus"
                },
                {
                    "first": "Diane",
                    "initial": "D.",
                    "last": "McKenna-Yasek"
                },
                {
                    "first": "Annarueber",
                    "initial": "A.",
                    "last": "Cayabyab"
                },
                {
                    "first": "Sandra M.",
                    "initial": "S.M.",
                    "last": "Gaston"
                },
                {
                    "first": "Ralph",
                    "initial": "R.",
                    "last": "Berger"
                },
                {
                    "first": "Rudolph E.",
                    "initial": "R.E.",
                    "last": "Tanzi"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Halperin"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Herzfeldt"
                },
                {
                    "first": "Raymond Van",
                    "initial": "R.V.",
                    "last": "Den Bergh"
                },
                {
                    "first": "Wu Yen",
                    "initial": "W.Y.",
                    "last": "Hung"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Bird"
                },
                {
                    "first": "Gang",
                    "initial": "G.",
                    "last": "Deng"
                },
                {
                    "first": "Donald W.",
                    "initial": "D.W.",
                    "last": "Mulder"
                },
                {
                    "first": "Celestine",
                    "initial": "C.",
                    "last": "Smyth"
                },
                {
                    "first": "Nigel G.",
                    "initial": "N.G.",
                    "last": "Laing"
                },
                {
                    "first": "Edwin",
                    "initial": "E.",
                    "last": "Soriano"
                },
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Pericak-Vance"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Haines"
                },
                {
                    "first": "Guy A.",
                    "initial": "G.A.",
                    "last": "Rouleau"
                },
                {
                    "first": "James S.",
                    "initial": "J.S.",
                    "last": "Gusella"
                },
                {
                    "first": "H. Robert",
                    "initial": "H.R.",
                    "last": "Horvitz"
                },
                {
                    "first": "Robert H.",
                    "initial": "R.H.",
                    "last": "Brown"
                }
            ],
            "doi": "10.1038/362059a0",
            "firstpage": "59",
            "issn": "00280836",
            "lastpage": "62",
            "pmid": "8446170",
            "pub_year": 1993,
            "title": "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis",
            "volume": "362"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Lucie I.",
                    "initial": "L.I.",
                    "last": "Bruijn"
                },
                {
                    "first": "Timothy M.",
                    "initial": "T.M.",
                    "last": "Miller"
                },
                {
                    "first": "Don W.",
                    "initial": "D.W.",
                    "last": "Cleveland"
                }
            ],
            "doi": "10.1146/annurev.neuro.27.070203.144244",
            "firstpage": "723",
            "issn": "0147006X",
            "lastpage": "749",
            "pmid": "15217349",
            "pub_year": 2004,
            "title": "Unraveling the mechanisms involved in motor neuron degeneration in ALS",
            "volume": "27"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Francois",
                    "initial": "F.",
                    "last": "Gros-Louis"
                },
                {
                    "first": "Genevi\u00e8ve",
                    "initial": "G.",
                    "last": "Soucy"
                },
                {
                    "first": "Roxanne",
                    "initial": "R.",
                    "last": "Larivi\u00e8re"
                },
                {
                    "first": "Jean Pierre",
                    "initial": "J.P.",
                    "last": "Julien"
                }
            ],
            "doi": "10.1111/j.1471-4159.2010.06683.x",
            "firstpage": "1188",
            "issn": "00223042",
            "lastpage": "1199",
            "pmid": "20345765",
            "pub_year": 2010,
            "title": "Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS",
            "volume": "113"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Shigeko",
                    "initial": "S.",
                    "last": "Takeuchi"
                },
                {
                    "first": "Noriko",
                    "initial": "N.",
                    "last": "Fujiwara"
                },
                {
                    "first": "Akemi",
                    "initial": "A.",
                    "last": "Ido"
                },
                {
                    "first": "Miki",
                    "initial": "M.",
                    "last": "Oono"
                },
                {
                    "first": "Yuki",
                    "initial": "Y.",
                    "last": "Takeuchi"
                },
                {
                    "first": "Minako",
                    "initial": "M.",
                    "last": "Tateno"
                },
                {
                    "first": "Keiichiro",
                    "initial": "K.",
                    "last": "Suzuki"
                },
                {
                    "first": "Ryosuke",
                    "initial": "R.",
                    "last": "Takahashi"
                },
                {
                    "first": "Ikuo",
                    "initial": "I.",
                    "last": "Tooyama"
                },
                {
                    "first": "Naoyuki",
                    "initial": "N.",
                    "last": "Taniguchi"
                },
                {
                    "first": "Jean Pierre",
                    "initial": "J.P.",
                    "last": "Julien"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Urushitani"
                }
            ],
            "doi": "10.1097/NEN.0b013e3181f4a90a",
            "firstpage": "1044",
            "issn": "00223069",
            "lastpage": "1056",
            "pmid": "20838241",
            "pub_year": 2010,
            "title": "Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice",
            "volume": "69"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Hsueh Ning",
                    "initial": "H.N.",
                    "last": "Liu"
                },
                {
                    "first": "Sonja",
                    "initial": "S.",
                    "last": "Tjostheim"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "da Silva"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Taylor"
                },
                {
                    "first": "Beibei",
                    "initial": "B.",
                    "last": "Zhao"
                },
                {
                    "first": "Rishi",
                    "initial": "R.",
                    "last": "Rakhit"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Brown"
                },
                {
                    "first": "Avijit",
                    "initial": "A.",
                    "last": "Chakrabartty"
                },
                {
                    "first": "Joanne",
                    "initial": "J.",
                    "last": "McLaurin"
                },
                {
                    "first": "Janice",
                    "initial": "J.",
                    "last": "Robertson"
                }
            ],
            "doi": "10.1523/JNEUROSCI.5053-11.2012",
            "firstpage": "8791",
            "issn": "02706474",
            "lastpage": "8799",
            "pmid": "22745481",
            "pub_year": 2012,
            "title": "Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis",
            "volume": "32"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Urushitani"
                },
                {
                    "first": "Samer Abou",
                    "initial": "S.A.",
                    "last": "Ezzi"
                },
                {
                    "first": "Jean Pierre",
                    "initial": "J.P.",
                    "last": "Julien"
                }
            ],
            "doi": "10.1073/pnas.0606201104",
            "firstpage": "2495",
            "issn": "00278424",
            "lastpage": "2500",
            "pmid": "17277077",
            "pub_year": 2007,
            "title": "Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis",
            "volume": "104"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Will C.",
                    "initial": "W.C.",
                    "last": "Guest"
                },
                {
                    "first": "J. Maxwell",
                    "initial": "J.M.",
                    "last": "Silverman"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Pokrishevsky"
                },
                {
                    "first": "Megan A.",
                    "initial": "M.A.",
                    "last": "O'Neill"
                },
                {
                    "first": "Leslie I.",
                    "initial": "L.I.",
                    "last": "Grad"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                }
            ],
            "doi": "10.1080/15287394.2011.618967",
            "firstpage": "1433",
            "issn": "15287394",
            "lastpage": "1459",
            "pmid": "22043906",
            "pub_year": 2011,
            "title": "Generalization of the prion hypothesis to other neurodegenerative diseases: An imperfect fit",
            "volume": "74"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Fabrizio",
                    "initial": "F.",
                    "last": "Chiti"
                },
                {
                    "first": "Christopher M.",
                    "initial": "C.M.",
                    "last": "Dobson"
                }
            ],
            "doi": "10.1146/annurev.biochem.75.101304.123901",
            "firstpage": "333",
            "issn": "00664154",
            "lastpage": "366",
            "pmid": "16756495",
            "pub_year": 2006,
            "title": "Protein misfolding, functional amyloid, and human disease",
            "volume": "75"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Napper"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                }
            ],
            "doi": "10.2217/imt.10.3",
            "firstpage": "269",
            "issn": "1750743X",
            "lastpage": "282",
            "pmid": "20635933",
            "pub_year": 2010,
            "title": "Immunotherapy for prion diseases: Opportunities and obstacles",
            "volume": "2"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Kristen",
                    "initial": "K.",
                    "last": "Marciniuk"
                },
                {
                    "first": "Ryan",
                    "initial": "R.",
                    "last": "Taschuk"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Napper"
                }
            ],
            "doi": "10.1155/2013/473706",
            "issn": "17402522",
            "pmid": "24228054",
            "pub_year": 2013,
            "title": "Evidence for prion-like mechanisms in several neurodegenerative diseases: Potential implications for immunotherapy",
            "volume": "2013"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Hedlin"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Jyotsana",
                    "initial": "J.",
                    "last": "Gupta"
                },
                {
                    "first": "Lorne A.",
                    "initial": "L.A.",
                    "last": "Babiuk"
                },
                {
                    "first": "Andrew A.",
                    "initial": "A.A.",
                    "last": "Potter"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Griebel"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Napper"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.10.134",
            "firstpage": "981",
            "issn": "0264410X",
            "lastpage": "988",
            "pmid": "19925901",
            "pub_year": 2010,
            "title": "Design and delivery of a cryptic PrPC epitope for induction of PrPSc-specific antibody responses",
            "volume": "28"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Kristen",
                    "initial": "K.",
                    "last": "Marciniuk"
                },
                {
                    "first": "Pekka",
                    "initial": "P.",
                    "last": "M\u00e4\u00e4tt\u00e4nen"
                },
                {
                    "first": "Ryan",
                    "initial": "R.",
                    "last": "Taschuk"
                },
                {
                    "first": "T. Dean",
                    "initial": "T.D.",
                    "last": "Airey"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Potter"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Griebel"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Napper"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.01.027",
            "firstpage": "1988",
            "issn": "0264410X",
            "lastpage": "1997",
            "pmid": "24486363",
            "pub_year": 2014,
            "title": "Development of a Multivalent, PrPSc-Specific Prion Vaccine through Rational Optimization of Three Disease-Specific Epitopes",
            "volume": "32"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Jennifer Stine",
                    "initial": "J.S.",
                    "last": "Elam"
                },
                {
                    "first": "Alexander B.",
                    "initial": "A.B.",
                    "last": "Taylor"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Strange"
                },
                {
                    "first": "Svetlana",
                    "initial": "S.",
                    "last": "Antonyuk"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Doucette"
                },
                {
                    "first": "Jorge A.",
                    "initial": "J.A.",
                    "last": "Rodriguez"
                },
                {
                    "first": "S. Samar",
                    "initial": "S.S.",
                    "last": "Hasnain"
                },
                {
                    "first": "Lawrence J.",
                    "initial": "L.J.",
                    "last": "Hayward"
                },
                {
                    "first": "Joan Selverstone",
                    "initial": "J.S.",
                    "last": "Valentine"
                },
                {
                    "first": "Todd O.",
                    "initial": "T.O.",
                    "last": "Yeates"
                },
                {
                    "first": "P. John",
                    "initial": "P.J.",
                    "last": "Hart"
                }
            ],
            "doi": "10.1038/nsb935",
            "firstpage": "461",
            "issn": "10728368",
            "lastpage": "467",
            "pmid": "12754496",
            "pub_year": 2003,
            "title": "Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS",
            "volume": "10"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Sagar D.",
                    "initial": "S.D.",
                    "last": "Khare"
                },
                {
                    "first": "Kyle C.",
                    "initial": "K.C.",
                    "last": "Wilcox"
                },
                {
                    "first": "Peng",
                    "initial": "P.",
                    "last": "Gong"
                },
                {
                    "first": "Nikolay V.",
                    "initial": "N.V.",
                    "last": "Dokholyan"
                }
            ],
            "doi": "10.1002/prot.20629",
            "firstpage": "617",
            "issn": "08873585",
            "lastpage": "632",
            "pmid": "16152647",
            "pub_year": 2005,
            "title": "Sequence and structural determinants of Cu, Zn superoxide dismutase aggregation",
            "volume": "61"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Xubiao",
                    "initial": "X.",
                    "last": "Peng"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                },
                {
                    "first": "Steven S.",
                    "initial": "S.S.",
                    "last": "Plotkin"
                }
            ],
            "doi": "10.1021/acs.jpcb.8b07680",
            "firstpage": "11662",
            "issn": "15206106",
            "lastpage": "11676",
            "pmid": "30351123",
            "pub_year": 2018,
            "title": "Prediction of Misfolding-Specific Epitopes in SOD1 Using Collective Coordinates",
            "volume": "122"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Kristen",
                    "initial": "K.",
                    "last": "Marciniuk"
                },
                {
                    "first": "Brett",
                    "initial": "B.",
                    "last": "Trost"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Napper"
                }
            ],
            "doi": "10.1093/bioinformatics/btv136",
            "firstpage": "2388",
            "issn": "13674803",
            "lastpage": "2390",
            "pmid": "25750418",
            "pub_year": 2015,
            "title": "EpIC: A rational pipeline for epitope immunogenicity characterization",
            "volume": "31"
        },
        "b0110": null,
        "b0115": {
            "authors": [
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Petrushina"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Tran"
                },
                {
                    "first": "Nadya",
                    "initial": "N.",
                    "last": "Sadzikava"
                },
                {
                    "first": "Anahit",
                    "initial": "A.",
                    "last": "Ghochikyan"
                },
                {
                    "first": "Vitaly",
                    "initial": "V.",
                    "last": "Vasilevko"
                },
                {
                    "first": "Michael G.",
                    "initial": "M.G.",
                    "last": "Agadjanyan"
                },
                {
                    "first": "David H.",
                    "initial": "D.H.",
                    "last": "Cribbs"
                }
            ],
            "doi": "10.1016/S0304-3940(02)01357-5",
            "firstpage": "5",
            "issn": "03043940",
            "lastpage": "8",
            "pmid": "12565127",
            "pub_year": 2003,
            "title": "Importance of IgG2c isotype in the immune response to \u03b2-amyloid in amyloid precursor protein/transgenic mice",
            "volume": "338"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Samer Abou",
                    "initial": "S.A.",
                    "last": "Ezzi"
                },
                {
                    "first": "Roxanne",
                    "initial": "R.",
                    "last": "Larivi\u00e8re"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Urushitani"
                },
                {
                    "first": "Jean Pierre",
                    "initial": "J.P.",
                    "last": "Julien"
                }
            ],
            "doi": "10.1111/j.1471-4159.2010.06979.x",
            "firstpage": "1102",
            "issn": "00223042",
            "lastpage": "1111",
            "pub_year": 2010,
            "title": "Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS",
            "volume": "115"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Barn\u00e9oud"
                },
                {
                    "first": "Jocelyne",
                    "initial": "J.",
                    "last": "Lolivier"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Sanger"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Scatton"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Moser"
                }
            ],
            "doi": "10.1097/00001756-199709080-00012",
            "firstpage": "2861",
            "issn": "09594965",
            "lastpage": "2865",
            "pmid": "9376520",
            "pub_year": 1997,
            "title": "Quantitative motor assessment in FALS mice: A longitudinal study",
            "volume": "8"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Mimoun",
                    "initial": "M.",
                    "last": "Azzouz"
                },
                {
                    "first": "G. Scott",
                    "initial": "G.S.",
                    "last": "Ralph"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Storkebaum"
                },
                {
                    "first": "Lucy E.",
                    "initial": "L.E.",
                    "last": "Walmsley"
                },
                {
                    "first": "Kyriacos A.",
                    "initial": "K.A.",
                    "last": "Mitrophanous"
                },
                {
                    "first": "Susan M.",
                    "initial": "S.M.",
                    "last": "Kingsman"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Carmellet"
                },
                {
                    "first": "Nicholas D.",
                    "initial": "N.D.",
                    "last": "Mazarakis"
                }
            ],
            "doi": "10.1038/nature02544",
            "firstpage": "413",
            "issn": "00280836",
            "lastpage": "417",
            "pmid": "15164063",
            "pub_year": 2004,
            "title": "VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model",
            "volume": "429"
        },
        "b0135": null,
        "b0140": {
            "authors": [
                {
                    "first": "Kristen",
                    "initial": "K.",
                    "last": "Marciniuk"
                },
                {
                    "first": "Ryan",
                    "initial": "R.",
                    "last": "Taschuk"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Napper"
                }
            ],
            "doi": "10.1007/978-1-4939-3387-7_37",
            "firstpage": "657",
            "issn": "10643745",
            "lastpage": "680",
            "pmid": "27076159",
            "pub_year": 2016,
            "title": "Methods and protocols for developing prion vaccines",
            "volume": "1403"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Leslie I.",
                    "initial": "L.I.",
                    "last": "Grad"
                },
                {
                    "first": "Will C.",
                    "initial": "W.C.",
                    "last": "Guest"
                },
                {
                    "first": "Anat",
                    "initial": "A.",
                    "last": "Yanai"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Pokrishevsky"
                },
                {
                    "first": "Megan A.",
                    "initial": "M.A.",
                    "last": "O'Neill"
                },
                {
                    "first": "Ebrima",
                    "initial": "E.",
                    "last": "Gibbs"
                },
                {
                    "first": "Valentyna",
                    "initial": "V.",
                    "last": "Semenchenko"
                },
                {
                    "first": "Masoud",
                    "initial": "M.",
                    "last": "Yousefi"
                },
                {
                    "first": "David S.",
                    "initial": "D.S.",
                    "last": "Wishart"
                },
                {
                    "first": "Steven S.",
                    "initial": "S.S.",
                    "last": "Plotkin"
                },
                {
                    "first": "Neil R.",
                    "initial": "N.R.",
                    "last": "Cashman"
                }
            ],
            "doi": "10.1073/pnas.1102645108",
            "firstpage": "16398",
            "issn": "00278424",
            "lastpage": "16403",
            "pmid": "21930926",
            "pub_year": 2011,
            "title": "Intermolecular transmission of superoxide dismutase 1 misfolding in living cells",
            "volume": "108"
        },
        "b0150": {
            "authors": [
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Qualls"
                },
                {
                    "first": "Mercedes",
                    "initial": "M.",
                    "last": "Prudencio"
                },
                {
                    "first": "Brittany Lt",
                    "initial": "B.L.",
                    "last": "Roberts"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Crosby"
                },
                {
                    "first": "Hilda",
                    "initial": "H.",
                    "last": "Brown"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Borchelt"
                }
            ],
            "doi": "10.1186/1750-1326-8-46",
            "issn": "17501326",
            "pmid": "24341866",
            "pub_year": 2013,
            "title": "Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1",
            "volume": "8"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Bergh"
                },
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Zetterstr\u00f6m"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Andersen"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Br\u00e4nnstr\u00f6m"
                },
                {
                    "first": "Karin S.",
                    "initial": "K.S.",
                    "last": "Graffmo"
                },
                {
                    "first": "P. Andreas",
                    "initial": "P.A.",
                    "last": "Jonsson"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Lang"
                },
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Danielsson"
                },
                {
                    "first": "Mikael",
                    "initial": "M.",
                    "last": "Oliveberg"
                },
                {
                    "first": "Stefan L.",
                    "initial": "S.L.",
                    "last": "Marklund"
                }
            ],
            "doi": "10.1073/pnas.1419228112",
            "firstpage": "4489",
            "issn": "00278424",
            "lastpage": "4494",
            "pmid": "25802384",
            "pub_year": 2015,
            "title": "Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping",
            "volume": "112"
        },
        "b0160": {
            "authors": [
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Gillam"
                },
                {
                    "first": "C. E.",
                    "initial": "C.E.",
                    "last": "Macphee"
                }
            ],
            "doi": "10.1088/0953-8984/25/37/373101",
            "issn": "09538984",
            "pmid": "23941964",
            "pub_year": 2013,
            "title": "Modelling amyloid fibril formation kinetics: Mechanisms of nucleation and growth",
            "volume": "25"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Chuang Chung",
                    "initial": "C.C.",
                    "last": "Lee"
                },
                {
                    "first": "Arpan",
                    "initial": "A.",
                    "last": "Nayak"
                },
                {
                    "first": "Ananthakrishnan",
                    "initial": "A.",
                    "last": "Sethuraman"
                },
                {
                    "first": "Georges",
                    "initial": "G.",
                    "last": "Belfort"
                },
                {
                    "first": "Gregory J.",
                    "initial": "G.J.",
                    "last": "McRae"
                }
            ],
            "doi": "10.1529/biophysj.106.098608",
            "firstpage": "3448",
            "issn": "00063495",
            "lastpage": "3458",
            "pmid": "17325005",
            "pub_year": 2007,
            "title": "A three-stage kinetic model of amyloid fibrillation",
            "volume": "92"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Elaheh",
                    "initial": "E.",
                    "last": "Ekhtiari Bidhendi"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Bergh"
                },
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Zetterstr\u00f6m"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Andersen"
                },
                {
                    "first": "Stefan L.",
                    "initial": "S.L.",
                    "last": "Marklund"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Br\u00e4nnstr\u00f6m"
                }
            ],
            "doi": "10.1172/JCI84360",
            "firstpage": "2249",
            "issn": "00219738",
            "lastpage": "2253",
            "pmid": "27140399",
            "pub_year": 2016,
            "title": "Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease",
            "volume": "126"
        },
        "b0175": {
            "authors": [
                {
                    "first": "T. M.",
                    "initial": "T.M.",
                    "last": "Shinnick"
                },
                {
                    "first": "J. G.",
                    "initial": "J.G.",
                    "last": "Sutcliffe"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Green"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Lerner"
                }
            ],
            "doi": "10.1146/annurev.mi.37.100183.002233",
            "firstpage": "425",
            "issn": "00664227",
            "lastpage": "446",
            "pmid": "6357058",
            "pub_year": 1983,
            "title": "Synthetic peptide immunogens as vaccines.",
            "volume": "37"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Claudio",
                    "initial": "C.",
                    "last": "Soto"
                }
            ],
            "doi": "10.1073/pnas.0811625106",
            "firstpage": "10",
            "issn": "00278424",
            "lastpage": "11",
            "pmid": "19118191",
            "pub_year": 2009,
            "title": "Constraining the loop, releasing prion infectivity",
            "volume": "106"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Janus"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Pearson"
                },
                {
                    "first": "Jo Anne",
                    "initial": "J.A.",
                    "last": "McLaurin"
                },
                {
                    "first": "Paul M.",
                    "initial": "P.M.",
                    "last": "Mathews"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Jiang"
                },
                {
                    "first": "Stephen D.",
                    "initial": "S.D.",
                    "last": "Schmidt"
                },
                {
                    "first": "M. Azhar",
                    "initial": "M.A.",
                    "last": "Chishti"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Horne"
                },
                {
                    "first": "Donna",
                    "initial": "D.",
                    "last": "Heslin"
                },
                {
                    "first": "Janet",
                    "initial": "J.",
                    "last": "French"
                },
                {
                    "first": "Howard T.J.",
                    "initial": "H.T.J.",
                    "last": "Mount"
                },
                {
                    "first": "Ralph A.",
                    "initial": "R.A.",
                    "last": "Nixon"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Mercken"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Bergeron"
                },
                {
                    "first": "Paul E.",
                    "initial": "P.E.",
                    "last": "Fraser"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "St George-Hyslop"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Westaway"
                }
            ],
            "doi": "10.1038/35050110",
            "firstpage": "979",
            "issn": "00280836",
            "lastpage": "982",
            "pmid": "11140685",
            "pub_year": 2000,
            "title": "A\u03b2 peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease",
            "volume": "408"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Mandler"
                },
                {
                    "first": "Elvira",
                    "initial": "E.",
                    "last": "Valera"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Rockenstein"
                },
                {
                    "first": "Harald",
                    "initial": "H.",
                    "last": "Weninger"
                },
                {
                    "first": "Christina",
                    "initial": "C.",
                    "last": "Patrick"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Adame"
                },
                {
                    "first": "Radmila",
                    "initial": "R.",
                    "last": "Santic"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Meindl"
                },
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Vigl"
                },
                {
                    "first": "Oskar",
                    "initial": "O.",
                    "last": "Smrzka"
                },
                {
                    "first": "Achim",
                    "initial": "A.",
                    "last": "Schneeberger"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Mattner"
                },
                {
                    "first": "Eliezer",
                    "initial": "E.",
                    "last": "Masliah"
                }
            ],
            "doi": "10.1007/s00401-014-1256-4",
            "firstpage": "861",
            "issn": "00016322",
            "lastpage": "879",
            "pmid": "24525765",
            "pub_year": 2014,
            "title": "Next-generation active immunization approach for synucleinopathies: Implications for Parkinson's disease clinical trials",
            "volume": "127"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Dave",
                    "initial": "D.",
                    "last": "Morgan"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Diamond"
                },
                {
                    "first": "Paul E.",
                    "initial": "P.E.",
                    "last": "Gottschall"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Ugen"
                },
                {
                    "first": "Chad",
                    "initial": "C.",
                    "last": "Dickey"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Hardy"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Duff"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Jantzen"
                },
                {
                    "first": "Giovanni",
                    "initial": "G.",
                    "last": "DiCarlo"
                },
                {
                    "first": "Donna",
                    "initial": "D.",
                    "last": "Wilcock"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Connor"
                },
                {
                    "first": "Jaime",
                    "initial": "J.",
                    "last": "Hatcher"
                },
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Hope"
                },
                {
                    "first": "Marcia",
                    "initial": "M.",
                    "last": "Gordon"
                },
                {
                    "first": "Gary W.",
                    "initial": "G.W.",
                    "last": "Arendash"
                }
            ],
            "doi": "10.1038/35050116",
            "firstpage": "982",
            "issn": "00280836",
            "lastpage": "985",
            "pmid": "11140686",
            "pub_year": 2000,
            "title": "A \u03b2 peptide vaccination prevents memory loss in an animal model of Alzheimer's disease",
            "volume": "408"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Dale",
                    "initial": "D.",
                    "last": "Schenk"
                },
                {
                    "first": "Robin",
                    "initial": "R.",
                    "last": "Barbour"
                },
                {
                    "first": "Whitney",
                    "initial": "W.",
                    "last": "Dunn"
                },
                {
                    "first": "Grace",
                    "initial": "G.",
                    "last": "Gordon"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Grajeda"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Guldo"
                },
                {
                    "first": "Kang",
                    "initial": "K.",
                    "last": "Hu"
                },
                {
                    "first": "Jiping",
                    "initial": "J.",
                    "last": "Huang"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Johnson-Wood"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Khan"
                },
                {
                    "first": "Dora",
                    "initial": "D.",
                    "last": "Kholodenko"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Lee"
                },
                {
                    "first": "Zhenmei",
                    "initial": "Z.",
                    "last": "Liao"
                },
                {
                    "first": "Ivan",
                    "initial": "I.",
                    "last": "Lieberburg"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Motter"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Mutter"
                },
                {
                    "first": "Ferdie",
                    "initial": "F.",
                    "last": "Soriano"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Shopp"
                },
                {
                    "first": "Nicki",
                    "initial": "N.",
                    "last": "Vasquez"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Vandevert"
                },
                {
                    "first": "Shannan",
                    "initial": "S.",
                    "last": "Walker"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Wogulis"
                },
                {
                    "first": "Ted",
                    "initial": "T.",
                    "last": "Yednock"
                },
                {
                    "first": "Dora",
                    "initial": "D.",
                    "last": "Games"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Seubert"
                }
            ],
            "doi": "10.1038/22124",
            "firstpage": "173",
            "issn": "00280836",
            "lastpage": "177",
            "pmid": "10408445",
            "pub_year": 1999,
            "title": "Immunization with amyloid-\u03b2 attenuates Alzheimer disease-like pathology in the PDAPP mouse",
            "volume": "400"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Elvira",
                    "initial": "E.",
                    "last": "Valera"
                },
                {
                    "first": "Eliezer",
                    "initial": "E.",
                    "last": "Masliah"
                }
            ],
            "doi": "10.1016/j.pharmthera.2013.01.013",
            "firstpage": "311",
            "issn": "01637258",
            "lastpage": "322",
            "pmid": "23384597",
            "pub_year": 2013,
            "title": "Immunotherapy for neurodegenerative diseases: Focus on \u03b1- synucleinopathies",
            "volume": "138"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Akemi",
                    "initial": "A.",
                    "last": "Ido"
                },
                {
                    "first": "Hidenao",
                    "initial": "H.",
                    "last": "Fukuyama"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Urushitani"
                }
            ],
            "doi": "10.3390/ijms12106980",
            "firstpage": "6980",
            "issn": "14220067",
            "lastpage": "7003",
            "pmid": "22072931",
            "pub_year": 2011,
            "title": "Protein misdirection inside and outside motor neurons in amyotrophic lateral sclerosis (ALS): A possible clue for therapeutic strategies",
            "volume": "12"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Kasia",
                    "initial": "K.",
                    "last": "Lobello"
                },
                {
                    "first": "J. Michael",
                    "initial": "J.M.",
                    "last": "Ryan"
                },
                {
                    "first": "Enchi",
                    "initial": "E.",
                    "last": "Liu"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Rippon"
                },
                {
                    "first": "Ronald",
                    "initial": "R.",
                    "last": "Black"
                }
            ],
            "doi": "10.1155/2012/628070",
            "issn": "20900252",
            "pub_year": 2012,
            "title": "Targeting beta amyloid: A clinical review of immunotherapeutic approaches in Alzheimer's disease"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Amber L.",
                    "initial": "A.L.",
                    "last": "Southwell"
                },
                {
                    "first": "Paul H.",
                    "initial": "P.H.",
                    "last": "Patterson"
                }
            ],
            "doi": "10.1515/REVNEURO.2010.21.4.273",
            "firstpage": "273",
            "issn": "03341763",
            "lastpage": "287",
            "pub_year": 2010,
            "title": "Antibody therapy in neurodegenerative disease",
            "volume": "21"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Panza"
                },
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Logroscino"
                },
                {
                    "first": "Bruno P.",
                    "initial": "B.P.",
                    "last": "Imbimbo"
                },
                {
                    "first": "Vincenzo",
                    "initial": "V.",
                    "last": "Solfrizzi"
                }
            ],
            "doi": "10.1097/YCO.0000000000000041",
            "firstpage": "128",
            "issn": "09517367",
            "lastpage": "137",
            "pmid": "24445401",
            "pub_year": 2014,
            "title": "Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?",
            "volume": "27"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Panza"
                },
                {
                    "first": "Vincenzo",
                    "initial": "V.",
                    "last": "Solfrizzi"
                },
                {
                    "first": "Bruno P.",
                    "initial": "B.P.",
                    "last": "Imbimbo"
                },
                {
                    "first": "Rosanna",
                    "initial": "R.",
                    "last": "Tortelli"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Santamato"
                },
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Logroscino"
                }
            ],
            "doi": "10.1586/1744666X.2014.883921",
            "firstpage": "405",
            "issn": "1744666X",
            "lastpage": "419",
            "pmid": "24490853",
            "pub_year": 2014,
            "title": "Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: The way forward",
            "volume": "10"
        },
        "b0235": {
            "authors": [
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Masliah"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Hansen"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Adame"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Crews"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Bard"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Seubert"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Games"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Kirby"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Schenk"
                }
            ],
            "doi": "10.1212/01.WNL.0000148590.39911.DF",
            "firstpage": "129",
            "issn": "00283878",
            "lastpage": "131",
            "pmid": "15642916",
            "pub_year": 2005,
            "title": "A\u03b2 vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease",
            "volume": "64"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Dale",
                    "initial": "D.",
                    "last": "Schenk"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Hagen"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Seubert"
                }
            ],
            "doi": "10.1016/j.coi.2004.07.012",
            "firstpage": "599",
            "issn": "09527915",
            "lastpage": "606",
            "pmid": "15342006",
            "pub_year": 2004,
            "title": "Current progress in beta-amyloid immunotherapy",
            "volume": "16"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Alvaro",
                    "initial": "A.",
                    "last": "Barrera-Ocampo"
                },
                {
                    "first": "Francisco",
                    "initial": "F.",
                    "last": "Lopera"
                }
            ],
            "firstpage": "203",
            "issn": "16579534",
            "lastpage": "212",
            "pmid": "28293044",
            "pub_year": 2016,
            "title": "Amyloid-beta immunotherapy: the hope for Alzheimer disease?",
            "volume": "47"
        },
        "b0250": {
            "authors": [
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Orgogozo"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Gilman"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Dartigues"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Laurent"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Puel"
                },
                {
                    "first": "L. C.",
                    "initial": "L.C.",
                    "last": "Kirby"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Jouanny"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Dubois"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Eisner"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Flitman"
                },
                {
                    "first": "B. F.",
                    "initial": "B.F.",
                    "last": "Michel"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Boada"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Frank"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Hock"
                }
            ],
            "doi": "10.1212/01.WNL.0000073623.84147.A8",
            "firstpage": "46",
            "issn": "00283878",
            "lastpage": "54",
            "pmid": "12847155",
            "pub_year": 2003,
            "title": "Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization",
            "volume": "61"
        },
        "b0255": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Gilman"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Koller"
                },
                {
                    "first": "R. S.",
                    "initial": "R.S.",
                    "last": "Black"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Jenkins"
                },
                {
                    "first": "S. G.",
                    "initial": "S.G.",
                    "last": "Griffith"
                },
                {
                    "first": "N. C.",
                    "initial": "N.C.",
                    "last": "Fox"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Eisner"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Kirby"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Boada Rovira"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Forette"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Orgogozo"
                }
            ],
            "doi": "10.1212/01.WNL.0000159740.16984.3C",
            "firstpage": "1553",
            "issn": "00283878",
            "lastpage": "1562",
            "pmid": "15883316",
            "pub_year": 2005,
            "title": "Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial",
            "volume": "64"
        },
        "b0260": {
            "authors": [
                {
                    "first": "Jeff",
                    "initial": "J.",
                    "last": "Sevigny"
                },
                {
                    "first": "Ping",
                    "initial": "P.",
                    "last": "Chiao"
                },
                {
                    "first": "Thierry",
                    "initial": "T.",
                    "last": "Bussi\u00e8re"
                },
                {
                    "first": "Paul H.",
                    "initial": "P.H.",
                    "last": "Weinreb"
                },
                {
                    "first": "Leslie",
                    "initial": "L.",
                    "last": "Williams"
                },
                {
                    "first": "Marcel",
                    "initial": "M.",
                    "last": "Maier"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Dunstan"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Salloway"
                },
                {
                    "first": "Tianle",
                    "initial": "T.",
                    "last": "Chen"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Ling"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "O'Gorman"
                },
                {
                    "first": "Fang",
                    "initial": "F.",
                    "last": "Qian"
                },
                {
                    "first": "Mahin",
                    "initial": "M.",
                    "last": "Arastu"
                },
                {
                    "first": "Mingwei",
                    "initial": "M.",
                    "last": "Li"
                },
                {
                    "first": "Sowmya",
                    "initial": "S.",
                    "last": "Chollate"
                },
                {
                    "first": "Melanie S.",
                    "initial": "M.S.",
                    "last": "Brennan"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Quintero-Monzon"
                },
                {
                    "first": "Robert H.",
                    "initial": "R.H.",
                    "last": "Scannevin"
                },
                {
                    "first": "H. Moore",
                    "initial": "H.M.",
                    "last": "Arnold"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Engber"
                },
                {
                    "first": "Kenneth",
                    "initial": "K.",
                    "last": "Rhodes"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Ferrero"
                },
                {
                    "first": "Yaming",
                    "initial": "Y.",
                    "last": "Hang"
                },
                {
                    "first": "Alvydas",
                    "initial": "A.",
                    "last": "Mikulskis"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Grimm"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Hock"
                },
                {
                    "first": "Roger M.",
                    "initial": "R.M.",
                    "last": "Nitsch"
                },
                {
                    "first": "Alfred",
                    "initial": "A.",
                    "last": "Sandrock"
                }
            ],
            "doi": "10.1038/nature19323",
            "firstpage": "50",
            "issn": "00280836",
            "lastpage": "56",
            "pmid": "27582220",
            "pub_year": 2016,
            "title": "The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease",
            "volume": "537"
        },
        "b0265": {
            "authors": [
                {
                    "first": "Kathleen S.",
                    "initial": "K.S.",
                    "last": "Molnar"
                },
                {
                    "first": "N. Murat",
                    "initial": "N.M.",
                    "last": "Karabacak"
                },
                {
                    "first": "Joshua L.",
                    "initial": "J.L.",
                    "last": "Johnson"
                },
                {
                    "first": "Qi",
                    "initial": "Q.",
                    "last": "Wang"
                },
                {
                    "first": "Ashutoshi",
                    "initial": "A.",
                    "last": "Tiwari"
                },
                {
                    "first": "Lawrence J.",
                    "initial": "L.J.",
                    "last": "Hayward"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Coales"
                },
                {
                    "first": "Yoshitomo",
                    "initial": "Y.",
                    "last": "Hamuro"
                },
                {
                    "first": "Jeffrey N.",
                    "initial": "J.N.",
                    "last": "Agar"
                }
            ],
            "doi": "10.1074/jbc.M109.023945",
            "firstpage": "30965",
            "issn": "00219258",
            "lastpage": "30973",
            "pmid": "19635794",
            "pub_year": 2009,
            "title": "A common property of amyotrophic lateral sclerosis-associated variants. Destabilization of the copper/zinc superoxide dismutase electrostatic loop",
            "volume": "284"
        },
        "b0270": {
            "authors": [
                {
                    "first": "Melissa S.",
                    "initial": "M.S.",
                    "last": "Rotunno"
                },
                {
                    "first": "Daryl A.",
                    "initial": "D.A.",
                    "last": "Bosco"
                }
            ],
            "doi": "10.3389/fncel.2013.00253",
            "issn": "16625102",
            "pub_year": 2013,
            "title": "An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis",
            "volume": "7"
        }
    },
    "body_text": [
        {
            "endOffset": 22419,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0015",
            "sentence": "Therefore, to formulate a Th2-biased vaccine with robust and durable antibody responses, we chose tgG as the carrier in this study.",
            "startOffset": 22288,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 38738,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0090",
            "sentence": "Our data demonstrates that mere two injections and 10 \u03bcg of vaccine each time were sufficient to induce robust antibody responses that were well sustained up to the endpoints evaluated in both pilot studies.",
            "startOffset": 38531,
            "title": "The choice of carrier"
        },
        {
            "endOffset": 25248,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 25247,
                    "startOffset": 25243
                }
            },
            "secId": "s0025",
            "sentence": "To characterize the therapeutic effectiveness of tgG-DSE2lim and tgG-DSE5b, we chose an indolent mouse model of ALS, hSOD1G37R line 29, which harbours the human G37R-SOD1 mutation and resembles symptomatic and pathological clinical features of ALS [24].",
            "startOffset": 24995,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in hSOD1G37R animals"
        },
        {
            "endOffset": 41172,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "In the current study, our design strategy of conformational epitopes is expected to not only neutralize existing misfolded SOD1 but also arrest further misfolding propagation by absorbing the \u201cseeds\u201d.",
            "startOffset": 40972,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 18480,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 18479,
                    "startOffset": 18472
                },
                "b0085": {
                    "endOffset": 18479,
                    "startOffset": 18472
                }
            },
            "secId": "s0005",
            "sentence": "These disease-specific epitopes (DSEs), presented in the context of an appropriate protein carrier system, have potential to induce antibody responses that are specific to the misfolded conformation, as we reported previously [16,17].",
            "startOffset": 18246,
            "title": "Introduction"
        },
        {
            "endOffset": 21500,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0015",
            "sentence": "To induce an antibody response against a self-protein, a carrier protein with T cell epitopes is required in the composition of an effective vaccine.",
            "startOffset": 21351,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 18656,
            "parents": [],
            "secId": "s0005",
            "sentence": "For the current investigation, we employed a similar strategy to direct an immune response specifically against regions of SOD1 that are only exposed upon unfolding/misfolding.",
            "startOffset": 18480,
            "title": "Introduction"
        },
        {
            "endOffset": 19281,
            "parents": [],
            "secId": "s0005",
            "sentence": "We report here that both vaccines display significant therapeutic efficacy alleviating disease phenotypes of hSOD1G37R animals.",
            "startOffset": 19154,
            "title": "Introduction"
        },
        {
            "endOffset": 24020,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 24009,
                    "startOffset": 24005
                }
            },
            "secId": "s0020",
            "sentence": "To characterize the immune response bias of tgG-DSE2lim \u00b1 PNGase F and tgG-DSE5b, we quantified the IgG2c and IgG1 antibody titres on week 7 serum samples as a measurement of Th1 and Th2 responses, respectively [23] (Fig. S2).",
            "startOffset": 23794,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 44970,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0105",
            "sentence": "This strongly supports the notion that a multivalent DSE vaccination approach may maximize the potential of arresting propagation of pathogenic protein misfolding, and as a result deliver an enhanced therapeutic efficacy.",
            "startOffset": 44749,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 32024,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "For efficacy studies in hSOD1G37R mice, 1:100 diluted sera were used.",
            "startOffset": 31955,
            "title": "Epitope-specific antibody response measurement"
        },
        {
            "endOffset": 16113,
            "parents": [],
            "secId": "s0005",
            "sentence": "Approximately 5\u201310% of ALS cases are familial (fALS), \u223c20% of which are associated with mutations in the gene encoding copper/zinc superoxide dismutase (SOD1), a cytosolic free radical scavenger enzyme.",
            "startOffset": 15911,
            "title": "Introduction"
        },
        {
            "endOffset": 44382,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0100",
            "sentence": "Therefore, the strong Th2-biased immune responses, in combination with the conformational selectivity of our DSE-based vaccines provide important proof-of-principle data to development of human vaccines with an improved safety and therapeutic/prophylactic outcome.",
            "startOffset": 44118,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 35555,
            "parents": [],
            "secId": "s0080",
            "sentence": "Both vaccines significantly improve the overall life expectancy of hSOD1G37R mice, with tgG-DSE2lim vaccinated animals displaying a \u223c 25% greater survival rate than tgG-DSE5b treated during earlier symptomatic stage of the disease.",
            "startOffset": 35324,
            "title": "Discussion"
        },
        {
            "endOffset": 16451,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 16313,
                    "startOffset": 16310
                }
            },
            "secId": "s0005",
            "sentence": "Since first discovered as a pathological protein of ALS in 1993 [6], over 150 mutations in SOD1 have been identified but the precise pathomechanisms associated with SOD1 mutations remain poorly understood.",
            "startOffset": 16246,
            "title": "Introduction"
        },
        {
            "endOffset": 20415,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 20414,
                    "startOffset": 20410
                }
            },
            "secId": "s0015",
            "sentence": "This unstructured fragment inserts itself into a groove formed between the aberrantly exposed \u03b2-sheets 5 and 6 of an adjacent SOD1 molecule to form a non-native protein interaction, which can then act as a template to recruit neighbouring SOD1 molecules and ultimately assembly into larger aggregates of amyloid-like filaments [18].",
            "startOffset": 20083,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 32088,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Antibody responses were read at 405 nm with a 490 nm reference.",
            "startOffset": 32025,
            "title": "Epitope-specific antibody response measurement"
        },
        {
            "endOffset": 45883,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0105",
            "sentence": "Therefore, the vaccine development strategy established in the current study can also be extended to these mutants in the future for the identification of additional lead epitopes targeting pathogenic SOD1, and ultimately be included in a multivalent vaccine formulation.",
            "startOffset": 45612,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 26758,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In contrast, tgG-DSE5b not only considerably delayed the disease onset (though it did not reach statistical significance, HLR2 p = 0.071) but also significantly slowed disease progression of hSOD1G37R animals compared to control group (HLR1 p = 0.013).",
            "startOffset": 26506,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 43125,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 43124,
                    "startOffset": 43114
                },
                "b0205": {
                    "endOffset": 43124,
                    "startOffset": 43114
                },
                "b0210": {
                    "endOffset": 43124,
                    "startOffset": 43114
                },
                "b0215": {
                    "endOffset": 43124,
                    "startOffset": 43114
                },
                "b0220": {
                    "endOffset": 43124,
                    "startOffset": 43114
                },
                "b0225": {
                    "endOffset": 43124,
                    "startOffset": 43114
                },
                "b0230": {
                    "endOffset": 43124,
                    "startOffset": 43114
                }
            },
            "secId": "s0100",
            "sentence": "A number of immunotherapy clinical trials have been conducted in an effort to develop treatment for neurodegenerative diseases, which have provided not only critical proof-of-principle data for the feasibility of immunotherapy but also valuable lessons for improvement in the future [14,41\u201346].",
            "startOffset": 42831,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 28186,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Trial endpoint was defined as when the animal was unable to right itself on either side within 30 s after being placed on its side.",
            "startOffset": 28055,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 20670,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 20669,
                    "startOffset": 20665
                }
            },
            "secId": "s0015",
            "sentence": "One of these sequences, 35IKGLTEGLHGF45, forms a crossover loop between \u03b2-sheets 3 and 4 in the native SOD1 [19].",
            "startOffset": 20557,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 46294,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0105",
            "sentence": "Therefore, a multivalent DSE-SOD1 vaccine will not only provide a valuable prophylactic/therapeutic intervention for fALS-SOD1 patients and mutant SOD1 carriers, but also benefit at least a proportion of sALS patients.",
            "startOffset": 46076,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 28332,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "As shown in Fig. 3D, both vaccines significantly improved the overall survival of hSOD1G37R animals (tgG-DSE2lim p = 0.045; tgG-DSE5b p = 0.037).",
            "startOffset": 28187,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 30256,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The gene corresponding to each DSE repeat motif was synthesized by Genscript (Piscataway, NJ, USA) into the pUC57 vector, and then sub-cloned into the tgG eukaryotic expression vector, pEB4.3-tgG-His, to generate tgG-DSE-His.",
            "startOffset": 30031,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 34317,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "One-way ANOVA on a ranked sum was performed to compare epitope-specific antibody titres of tgG-DSE2lim \u00b1 PNGase F and tgG-DSE5b in vaccinated normal C57BL/6 mice at each serum collection time point.",
            "startOffset": 34119,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 33073,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "Behavioural studies were all conducted blind.",
            "startOffset": 33028,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 33871,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "If mice failed the test from the first attempt, two more times were repeated.",
            "startOffset": 33794,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 24928,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Together, the above data established that: (1) for all three vaccines, two immunizations were sufficient to elicit robust and sustained desirable Th2-biased antibody responses; (2) the presence of N-glycans in DSE2lim peptide had no effect on the magnitude of tgG-DSE2lim induced antibody responses; (3) tgG-DSE2lim induced a significantly stronger Th2 bias than tgG-DSE2lim PNGase F, and therefore only tgG-DSE2lim was used for subsequent efficacy studies.",
            "startOffset": 24471,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 35071,
            "parents": [],
            "secId": "s0080",
            "sentence": "Both vaccines elicit robust and sustained antibody responses, and demonstrate significant therapeutic efficacy on disease trajectory and survival in vaccinated hSOD1G37R mice.",
            "startOffset": 34896,
            "title": "Discussion"
        },
        {
            "endOffset": 37808,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "When inoculated into the spinal cords of hSOD1G85R mice, both strains altered disease trajectory differently, reminiscent of the differential clinical outcomes by tgG-DSE2lim and tgG-DSE5b observed in our study.",
            "startOffset": 37597,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 27295,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The motor function (strength, balance, coordination and endurance) of hSOD1G37R animals was measured using a rotarod apparatus.",
            "startOffset": 27168,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 40735,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 40734,
                    "startOffset": 40730
                }
            },
            "secId": "s0095",
            "sentence": "A major breakthrough came from a study by Liu et al. 2012, where a conformation-based peptide vaccine targeting the epitope \u201cSOD1 Exposed Dimer Interface (SEDI)\u201d, was developed and shown to attenuate disease phenotypes in mutant hSOD1 transgenic mice [10].",
            "startOffset": 40479,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 15326,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15325,
                    "startOffset": 15322
                }
            },
            "secId": "s0005",
            "sentence": "Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disease characterized by degeneration of motor neurons of the brain and spinal cord, leading to progressive paralysis of the affected individuals [1].",
            "startOffset": 15099,
            "title": "Introduction"
        },
        {
            "endOffset": 31664,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Each animal received a total of two subcutaneous injections with a 3-week interval.",
            "startOffset": 31581,
            "title": "Animal immunization"
        },
        {
            "endOffset": 30583,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "3 \u00d7 105 cells per well of 6-well plates were transfected with 2 \u03bcg tgG-DSE-His plasmid using TurboFect transfection reagent (ThermoFisher Scientific, Waltham, MA, USA).",
            "startOffset": 30415,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 39720,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "A key element in the development of a safe and efficacious immunotherapeutic for proteinopathies is the design of an epitope(s) that would specifically target the pathogenic species of a disease associated protein while sparing its native conformer.",
            "startOffset": 39471,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 41512,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "Comparison of the therapeutic efficacy in the hSOD1G37R model from the current study with previous vaccination trials demonstrates a potential of greater therapeutic efficacy of DSE-based peptide immunogens (tgG-DSE2lim, tgG-DSE5b, and SEDI) over a full-length mutant SOD1 (rec G93A) as an immunogen, e.g., delayed disease onset (Table 1).",
            "startOffset": 41173,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 29785,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "All procedures were conducted in accordance with the Canadian Council on Animal Care.",
            "startOffset": 29700,
            "title": "Animals"
        },
        {
            "endOffset": 33964,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "To declare that a mouse was unable to perform the test, they had to fail two weeks in a row.",
            "startOffset": 33872,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 35664,
            "parents": [],
            "secId": "s0080",
            "sentence": "These results indicate that tgG-DSE2lim and tgG-DSE5b influence disease course through different mechanisms.",
            "startOffset": 35556,
            "title": "Discussion"
        },
        {
            "endOffset": 45433,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 45297,
                    "startOffset": 45293
                }
            },
            "secId": "s0105",
            "sentence": "Given the differential efficacy profiles of tgG-DSE2lim and tgG-DSE5b in hSOD1G37R mice reported here, and the positive clinical outcomes from previous passive immunization studies [27], we foresee that a multivalent vaccination approach simultaneously targeting multiple DSEs within SOD1, e.g., DSE2lim, DSE5b, and DSE1a [27], may endow synergistic therapeutic benefits through targeting multiple species of misfolded SOD1 and/or multiple pathogenic mechanisms.",
            "startOffset": 44971,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 17384,
            "parents": [],
            "secId": "s0005",
            "sentence": "For immunotherapeutics, active immunotherapy (vaccination) has many advantages over passive immunotherapy by providing a more sustained protection without the requirement for repeated infusion of antibodies.",
            "startOffset": 17177,
            "title": "Introduction"
        },
        {
            "endOffset": 26229,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 26151,
                    "startOffset": 26147
                },
                "b0130": {
                    "endOffset": 26180,
                    "startOffset": 26176
                }
            },
            "secId": "s0030",
            "sentence": "To assess the impact of tgG-DSE2lim and tgG-DSE5b on disease trajectory, two well-established behavioural tests, hindlimb extension reflex (HLR) score [25] and rotarod performance [26], were performed on vaccinated hSOD1G37R animals.",
            "startOffset": 25996,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 24471,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "In addition, tgG-DSE2lim generated a significantly greater ratio of Th2/Th1 compared to tgG-DSE2lim PNGase F (p \u2264 0.001).",
            "startOffset": 24350,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 25787,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "As shown in Fig. 2, both vaccines elicited rapid and robust epitope-specific antibody responses as early as week 2.",
            "startOffset": 25672,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in hSOD1G37R animals"
        },
        {
            "endOffset": 28492,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The median lifespan of hSOD1G37R was 548 days for control group, which was extended to 598 and 591 days by tgG-DES2lim and tgG-DSE5b vaccination, respectively.",
            "startOffset": 28333,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 42680,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 42679,
                    "startOffset": 42675
                }
            },
            "secId": "s0100",
            "sentence": "Misfolded pathogenic proteins in these neurodegenerative diseases not only self-propagate intracellularly, but also can transmit between cells or even tissues [15].",
            "startOffset": 42516,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 30030,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 30029,
                    "startOffset": 30025
                }
            },
            "secId": "s0050",
            "sentence": "The sequences of DSE2lim and DSE5b were each presented in a (forward-back-back)4 repeat motif, which we previously found was more immunogenic than the single presentation of the epitope [16].",
            "startOffset": 29839,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 40971,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "SEDI is normally buried within the homodimer interface of native SOD1, but exposed upon disruption of the dimeric structure due to mutations or oxidation, and therefore presumably specifically targets unstable monomeric/misfolded SOD1.",
            "startOffset": 40736,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 15583,
            "parents": [],
            "secId": "s0005",
            "sentence": "The majority of patients die within 2\u20135 years of diagnosis due to progressive paralysis and eventual respiratory failure.",
            "startOffset": 15462,
            "title": "Introduction"
        },
        {
            "endOffset": 23350,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Epitope-specific antibody responses were monitored by enzyme-linked immunosorbent assay (ELISA), and the median titre for each cohort was plotted over all time points.",
            "startOffset": 23183,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 17616,
            "parents": [],
            "secId": "s0005",
            "sentence": "Moreover, a successful vaccination strategy against ALS will not only ameliorate disease course, but also provide a more economical therapy for patients requiring a lifetime of disease management, and improve their quality of life.",
            "startOffset": 17385,
            "title": "Introduction"
        },
        {
            "endOffset": 45611,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0265": {
                    "endOffset": 45610,
                    "startOffset": 45606
                }
            },
            "secId": "s0105",
            "sentence": "Notably, several wild-type-like and metal-binding-region SOD1 mutants identified in fALS have been shown to have significant perturbation in the electrostatic loop of SOD1 [53].",
            "startOffset": 45434,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 22606,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "We first set out to test the immunogenicity of tgG-DSE2lim and tgG-DSE5b vaccines in cohorts of 8 normal C57BL/6 mice.",
            "startOffset": 22488,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 30811,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Cultures were gradually scaled up, and 1.5 \u00d7 107 cells were then added to 30 ml serum free selection media.",
            "startOffset": 30704,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 23182,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Serum samples were collected at Day 0 immediately prior to vaccination and at weeks 3, 4, 7, 10, 14, 18 and 28 (endpoint) following the initial immunization.",
            "startOffset": 23025,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 36809,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "One explanation for the differential effects of tgG-DSE2lim and tgG-DSE5b on disease course and survival is that one DSE may be more accessible than the other during a particular phase of hSOD1G37R amyloidogenesis.",
            "startOffset": 36595,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 21780,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 21779,
                    "startOffset": 21775
                }
            },
            "secId": "s0015",
            "sentence": "Our previous research in the development of peptide-based vaccines against prion proteins demonstrates that the choice of carrier protein can significantly alter the magnitude and duration of epitope-specific antibody responses, and the bias of Th1 vs. Th2 immune responses [22].",
            "startOffset": 21501,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 34733,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "Kaplan\u2013Meier log-rank tests were performed to identify significant differences in the disease onset, progression, and lifespan of tgG-DSE2lim and tgG-DSE5b vaccinated hSOD1G37R animals.",
            "startOffset": 34548,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 38353,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 38352,
                    "startOffset": 38345
                },
                "b0180": {
                    "endOffset": 38352,
                    "startOffset": 38345
                }
            },
            "secId": "s0090",
            "sentence": "To develop an effective peptide-based vaccine against a self-protein, an important factor that can impact the magnitude and duration of antibody responses is the choice of a carrier protein [35,36].",
            "startOffset": 38155,
            "title": "The choice of carrier"
        },
        {
            "endOffset": 37934,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "Future work will be required to dissect the molecular mechanisms by which tgG-DSE2lim and tgG-DSE5b modify disease phenotypes.",
            "startOffset": 37808,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 43402,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 43401,
                    "startOffset": 43391
                },
                "b0235": {
                    "endOffset": 43401,
                    "startOffset": 43391
                },
                "b0240": {
                    "endOffset": 43401,
                    "startOffset": 43391
                },
                "b0245": {
                    "endOffset": 43401,
                    "startOffset": 43391
                }
            },
            "secId": "s0100",
            "sentence": "For instance, multiple Phase-III AD trials of A\u03b2 immunotherapies have been conducted within the past two decades, but their immune-targets did not necessarily distinguish the toxic oligomeric form of A\u03b2 (A\u03b2Os) from the non-harmful A\u03b2 species (monomers and fibrils) [45,47\u201349].",
            "startOffset": 43126,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 15911,
            "parents": [],
            "secId": "s0005",
            "sentence": "Radicava, a new FDA approved drug, has been reported to slow the rate of decline in physical function by 33% (ClinicalTrials.gov Identifier, NCT01492686).",
            "startOffset": 15757,
            "title": "Introduction"
        },
        {
            "endOffset": 31110,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Media was collected daily, clarified, and frozen for a period of 15 days.",
            "startOffset": 31037,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 41816,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "As such, only a proportion of rec G93A-induced antibodies neutralized misfolded hSOD1 in hSOD1G37R mice, thereby diluting the therapeutic efficacy.",
            "startOffset": 41669,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 29602,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The mouse line was maintained as hemizygotes by breeding with non-transgenic C57BL/6 mice.",
            "startOffset": 29512,
            "title": "Animals"
        },
        {
            "endOffset": 22788,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "The inverted sequence of DSE2lim, NGTKTSEEN, contained a predicted N-linked glycosylation site \u201cNGT\u201d, as confirmed by deglycosylation assay using N-glycosidase \u201cPNGase F\u201d (Fig. S1).",
            "startOffset": 22607,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 29131,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 29130,
                    "startOffset": 29126
                }
            },
            "secId": "s0035",
            "sentence": "The beneficial effect of tgG-DSE2lim on survival and its lack of efficacy on disease onset is consistent with our findings in a previous passive immunization study using a mouse monoclonal antibody raised against a longer form of DSE2lim [27].",
            "startOffset": 28888,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 33322,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "HLR was scored from 4 to 0 by lifting the animals by the base of the tail.",
            "startOffset": 33248,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 17726,
            "parents": [],
            "secId": "s0005",
            "sentence": "A prophylactic ALS vaccine would also offer an early precision prevention to genetic carriers of mutant SOD1.",
            "startOffset": 17617,
            "title": "Introduction"
        },
        {
            "endOffset": 46075,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0270": {
                    "endOffset": 46074,
                    "startOffset": 46070
                }
            },
            "secId": "s0105",
            "sentence": "Moreover, even though the contribution of wild-type SOD1 in ALS pathogenesis remains controversial, misfolded SOD1 has been observed in some post-mortem sporadic ALS (sALS) spinal cords [54].",
            "startOffset": 45884,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 17176,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 17175,
                    "startOffset": 17169
                },
                "b0045": {
                    "endOffset": 17175,
                    "startOffset": 17169
                },
                "b0050": {
                    "endOffset": 17175,
                    "startOffset": 17169
                },
                "b0055": {
                    "endOffset": 17175,
                    "startOffset": 17169
                }
            },
            "secId": "s0005",
            "sentence": "For ALS, both passive and active immunization studies have been carried out using motor neuron disease mouse models expressing human SOD1 mutations, often with positive therapeutic outcomes [8\u201311].",
            "startOffset": 16979,
            "title": "Introduction"
        },
        {
            "endOffset": 29699,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "hSOD1G37R progenies were screened by polymerase chain reaction using primers specific for hSOD1.",
            "startOffset": 29603,
            "title": "Animals"
        },
        {
            "endOffset": 20082,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 20081,
                    "startOffset": 20077
                }
            },
            "secId": "s0015",
            "sentence": "One region identified in X-ray crystal structure data from human native and ALS-associated mutant SOD1 proteins is the electrostatic loop (ESL), 126LGKGGNEESTKTGNAGS142, which is normally compact in native dimeric SOD1 but adopts an extended and unstructured conformation upon zinc depletion and unfolding of SOD1, as occurs in metal-deficient pathogenic SOD1 mutants [18].",
            "startOffset": 19709,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 42118,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "This further establishes the advantages of conformation-based DSE vaccines, which would not only specifically neutralize misfolded self-proteins without interfering with the normal function of the native conformer, but also minimize \u201cefficacy dilution\u201d and therefore enhance therapeutic effectiveness.",
            "startOffset": 41817,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 20556,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0015",
            "sentence": "Molecular dynamics simulation identified regions in SOD1 that were highly amyloidogenic for SOD1 aggregation under destabilizing conditions.",
            "startOffset": 20416,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 31856,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 31794,
                    "startOffset": 31787
                },
                "b0140": {
                    "endOffset": 31794,
                    "startOffset": 31787
                }
            },
            "secId": "s0060",
            "sentence": "Epitope-specific antibody responses were quantified by ELISA as described [16,28], using Lkt-DSE2lim and DSE5b peptide as the coating antigens.",
            "startOffset": 31713,
            "title": "Epitope-specific antibody response measurement"
        },
        {
            "endOffset": 31036,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Cultures were maintained at a density of \u223c 4 \u00d7 106 cells/ml.",
            "startOffset": 30976,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 18969,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 18778,
                    "startOffset": 18771
                },
                "b0095": {
                    "endOffset": 18778,
                    "startOffset": 18771
                },
                "b0100": {
                    "endOffset": 18968,
                    "startOffset": 18964
                }
            },
            "secId": "s0005",
            "sentence": "These regions were selected based on data from X-ray crystal structures and molecular dynamics simulation studies [18,19], as well as \u201ccollective coordinates\u201d, a computational algorithm modeling of unfolding energy initiated from an atomic resolution protein structure as deposited in the protein data base [20].",
            "startOffset": 18657,
            "title": "Introduction"
        },
        {
            "endOffset": 18064,
            "parents": [],
            "secId": "s0005",
            "sentence": "There is also the potential danger that antibodies immunoreactive to the native isoform of the protein could have deleterious autoimmune consequences, or inhibit the function of the natively folded protein.",
            "startOffset": 17858,
            "title": "Introduction"
        },
        {
            "endOffset": 26505,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "As shown in Fig. 3A & B, tgG-DSE2lim had no detectable effects on either disease onset or progression of hSOD1G37R animals.",
            "startOffset": 26382,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 36466,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "This is followed by an exponential growth phase, when additional chains continue to be recruited to the \u201cseeds\u201d, forming \u201cprotofibrils\u201d.",
            "startOffset": 36330,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 21351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0015",
            "sentence": "Together, the above studies led to the core epitope sequences of our DSE2lim and DSE5b, 131NEESTKTGN139 and 34SIKGLTEG41, respectively.",
            "startOffset": 21216,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 37290,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "Alternatively, DSE2lim and DSE5b may implicate the existence of at least two conformational species of hSOD1G37R that possess distinct kinetics of amyloidogenesis and consequent differential impacts on disease trajectory.",
            "startOffset": 37069,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 36329,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "The lag phase is the rate-limiting step for the formation of \u201cseeds\u201d, when misfolded polypeptide chains interact, often through hydrophobic regions that are normally masked in natively folded state and form oligomeric \u03b2-sheet structures.",
            "startOffset": 36092,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 40212,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "While each showed beneficial effects, drawbacks were that the immunogens were large and moreover contain epitopes representative of both native and misfolded SOD1 species, hence limiting the specificity and therapeutic efficacy, and also increasing the probability for cytotoxic pro-inflammatory cytokine release.",
            "startOffset": 39899,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 19505,
            "parents": [],
            "secId": "s0005",
            "sentence": "Our study validates the rationale for our conformation specific epitope based immuno-targeting strategy as a promising treatment for fALS-SOD1 patients and potentially a prophylactic approach for carriers of SOD1 mutations.",
            "startOffset": 19282,
            "title": "Introduction"
        },
        {
            "endOffset": 27168,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "When 75% of hSOD1G37R animals in each cohort reached HLR1, control animals were 524 days of age, which was delayed by an impressive 162 days for tgG-DSE5b vaccinated animals.",
            "startOffset": 26994,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 24170,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Th1 response releases pro-inflammatory cytokines that can be detrimental to the cell, whereas Th2 response promotes a protective antibody production.",
            "startOffset": 24021,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 34895,
            "parents": [],
            "secId": "s0080",
            "sentence": "In the present study, we developed two conformation-based DSE-SOD1 vaccines, tgG-DSE2lim and tgG-DSE5b.",
            "startOffset": 34792,
            "title": "Discussion"
        },
        {
            "endOffset": 33565,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "4: full extension of both hindlimbs for 2 s; 3: full extension of one hindlimb, second limb kicks back and forth; 2: both hindlimbs kick back and forth; 1: one limb kicks back and forth, second limb fully clasped; 0: both limbs fully clasped.",
            "startOffset": 33323,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 31954,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "For immunogenicity characterization in normal mice, serially diluted serum samples were analyzed.",
            "startOffset": 31857,
            "title": "Epitope-specific antibody response measurement"
        },
        {
            "endOffset": 16708,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 16707,
                    "startOffset": 16701
                },
                "b0045": {
                    "endOffset": 16707,
                    "startOffset": 16701
                },
                "b0050": {
                    "endOffset": 16707,
                    "startOffset": 16701
                },
                "b0055": {
                    "endOffset": 16707,
                    "startOffset": 16701
                }
            },
            "secId": "s0005",
            "sentence": "Therapeutic strategies have been directed to neutralizing existing misfolded SOD1 molecules [8\u201311].",
            "startOffset": 16609,
            "title": "Introduction"
        },
        {
            "endOffset": 24349,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "As shown in Fig. 1B, all three vaccines induced desirable Th2-biased responses (Th2/Th1 > 1).",
            "startOffset": 24256,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 30703,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Once near confluency, cells were transferred to DMEM selection media containing 2 \u03bcg/ml Puromycin, 25 \u03bcg/ml Gentamycin.",
            "startOffset": 30584,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 31307,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "For protein purification, culture media was concentrated using a centrifugal filter, and tgG-His proteins were purified with Ni-NTA agarose (QIAGEN, Hilden, Germany) following standard procedures.",
            "startOffset": 31111,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 39031,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 39030,
                    "startOffset": 39020
                },
                "b0185": {
                    "endOffset": 39030,
                    "startOffset": 39020
                },
                "b0190": {
                    "endOffset": 39030,
                    "startOffset": 39020
                },
                "b0195": {
                    "endOffset": 39030,
                    "startOffset": 39020
                },
                "b0200": {
                    "endOffset": 39030,
                    "startOffset": 39020
                }
            },
            "secId": "s0090",
            "sentence": "The doses and number of injections used in our study were significantly lower than those in previous peptide-based vaccination studies in mouse models of AD, PD, or ALS, where 30\u2013100 \u03bcg of immunogens and biweekly-monthly injections throughout disease course were typically applied [10,37\u201340].",
            "startOffset": 38739,
            "title": "The choice of carrier"
        },
        {
            "endOffset": 23509,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "As shown in Fig. 1A, all three vaccines induced robust antibody responses at comparable magnitude by week 3, rising thereafter and peaking at different times.",
            "startOffset": 23351,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 32227,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Titres were calculated as the reciprocal of the highest dilution with a positive reading 2 standard deviations above the negative control.",
            "startOffset": 32089,
            "title": "Epitope-specific antibody response measurement"
        },
        {
            "endOffset": 34096,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "Study endpoint was defined as when the animal was unable to right itself on either side within 30 s after being placed on its side.",
            "startOffset": 33965,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 25552,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Sex-balanced cohorts of 24 pre-symptomatic hSOD1G37R mice and 6 non-transgenic (non-Tg) littermate controls were vaccinated with tgG-DSE2lim, tgG-DSE5b, or control carrier tgG alone beginning at 13 weeks of age (\u223c4 weeks prior to the predicted onset of motor deficit), followed by a boost 3 weeks later.",
            "startOffset": 25249,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in hSOD1G37R animals"
        },
        {
            "endOffset": 27801,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In contrast, tgG-DSE2lim had no detectable effect on the motor function of hSOD1G37R animals throughout disease course.",
            "startOffset": 27682,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 25892,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Antibody responses to both vaccines were well sustained up to the latest time point assessed at week 18.",
            "startOffset": 25788,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in hSOD1G37R animals"
        },
        {
            "endOffset": 34781,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "p-values of p < 0.05 is considered significant.",
            "startOffset": 34734,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 39358,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0090",
            "sentence": "With readily human-translatable composition and formulation, our design of tgG-DSE based vaccines can expand the therapeutic potential of this platform in eventual human trials.",
            "startOffset": 39181,
            "title": "The choice of carrier"
        },
        {
            "endOffset": 15618,
            "parents": [],
            "secId": "s0005",
            "sentence": "To date, there is no cure for ALS.",
            "startOffset": 15584,
            "title": "Introduction"
        },
        {
            "endOffset": 32337,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "96-well plates were coated with 500 ng per well of appropriate antigen overnight at 4 \u00b0C.",
            "startOffset": 32248,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 35949,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 35872,
                    "startOffset": 35865
                },
                "b0150": {
                    "endOffset": 35872,
                    "startOffset": 35865
                },
                "b0155": {
                    "endOffset": 35872,
                    "startOffset": 35865
                }
            },
            "secId": "s0085",
            "sentence": "Given the current knowledge that human and mouse SOD1 exhibit little to no interaction in vivo [29\u201331], hSOD1G37R is likely the only source of misfolded SOD1 in hSOD1G37R animals.",
            "startOffset": 35770,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 37464,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 37463,
                    "startOffset": 37459
                }
            },
            "secId": "s0085",
            "sentence": "Interestingly, Bidhendi et al. (2016) identified two amyloidogenic strains of mutant SOD1 aggregates isolated from end-stage hSOD1G85R and hSOD1D90A mouse spinal cords [34].",
            "startOffset": 37291,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 33668,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "Rotarod performance was tested using a rotarod apparatus (IITC Life Science, Woodland Hills, CA, USA).",
            "startOffset": 33566,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 15461,
            "parents": [],
            "secId": "s0005",
            "sentence": "The average incidence of ALS is \u223c2 per 100,000 population each year, although the prevalence varies among geographic regions globally.",
            "startOffset": 15327,
            "title": "Introduction"
        },
        {
            "endOffset": 26292,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "HLR scores drop from 4 (healthy) to 0 with disease progression.",
            "startOffset": 26229,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 19708,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 19707,
                    "startOffset": 19701
                },
                "b0100": {
                    "endOffset": 19707,
                    "startOffset": 19701
                }
            },
            "secId": "s0015",
            "sentence": "A variety of approaches has been employed to delineate the molecular basis determining the conformations of native and misfolded SOD1 mutants [4,20].",
            "startOffset": 19559,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 38131,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "Understanding early cellular changes in response to tgG-DSE2lim and tgG-DSE5b treatments will potentially lead to the identification of upstream targets that contribute to the pathogenesis of ALS.",
            "startOffset": 37935,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 18245,
            "parents": [],
            "secId": "s0005",
            "sentence": "One way to address these concerns is to target regions of the protein whose exposure for antibody binding is dependent upon the protein misfolding to the pathological conformation.",
            "startOffset": 18065,
            "title": "Introduction"
        },
        {
            "endOffset": 39898,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 39897,
                    "startOffset": 39891
                },
                "b0055": {
                    "endOffset": 39897,
                    "startOffset": 39891
                }
            },
            "secId": "s0095",
            "sentence": "In the earlier ALS vaccination animal trials, recombinant full-length G93A-SOD1 (rec G93A) and misfolding-mimicking metal-free wild-type SOD1 had been used as immunogens [9,11].",
            "startOffset": 39721,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 23024,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Each animal received a total of two injections at week 0 and 3.",
            "startOffset": 22961,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 31580,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "For each immunogen, 10 \u03bcg of the recombinant protein was formulated in PBS with 30% Emulsigen-D for a final injection volume of 100 \u03bcl.",
            "startOffset": 31445,
            "title": "Animal immunization"
        },
        {
            "endOffset": 27459,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "As shown in Fig. 3C, 30% of control animals reached a rotarod performance failure by 506 days of age, which was delayed by 36 days in tgG-DSE5b vaccinated animals.",
            "startOffset": 27296,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 35323,
            "parents": [],
            "secId": "s0080",
            "sentence": "Interestingly, tgG-DSE2lim and tgG-DSE5b ameliorate disease phenotypes in a different fashion: tgG-DSE5b substantially delays disease onset and significantly slows disease progression, whereas tgG-DSE2lim essentially shows no effect on disease course.",
            "startOffset": 35072,
            "title": "Discussion"
        },
        {
            "endOffset": 42830,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0100",
            "sentence": "As such, successful immunotherapies specifically absorbing these pathogenic \u201cseeds\u201d would play a key role in both disease initiation and progression.",
            "startOffset": 42681,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 36091,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 36090,
                    "startOffset": 36080
                },
                "b0160": {
                    "endOffset": 36090,
                    "startOffset": 36080
                },
                "b0165": {
                    "endOffset": 36090,
                    "startOffset": 36080
                }
            },
            "secId": "s0085",
            "sentence": "The kinetics of amyloidogenesis is typically presented by a sigmoid curve consisting of a lag, growth, and eventual plateau phase [13,32,33].",
            "startOffset": 35950,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 43710,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 43537,
                    "startOffset": 43533
                },
                "b0250": {
                    "endOffset": 43648,
                    "startOffset": 43641
                },
                "b0255": {
                    "endOffset": 43648,
                    "startOffset": 43641
                },
                "b0260": {
                    "endOffset": 43709,
                    "startOffset": 43705
                }
            },
            "secId": "s0100",
            "sentence": "These non-specific A\u03b2 immunotherapies trials either failed to demonstrate meaningful efficacy, e.g., bapineuzumab and solanezumab [45]; raised safety concerns such as meningeoencephalitis as reported for the first AD vaccine trial AN1972 [50,51]; or had dose-limiting adverse effects, e.g., aducanumab [52].",
            "startOffset": 43403,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 44748,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 44747,
                    "startOffset": 44743
                }
            },
            "secId": "s0105",
            "sentence": "Our previous work in development of prion vaccines demonstrates that a multivalent vaccine based on three distinct DSEs in the misfolded form of prion protein, PrPSc, produces enhanced PrPSc-specific antibody titres compared to univalent vaccines derived from each individual DSE [17].",
            "startOffset": 44463,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 16978,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 16977,
                    "startOffset": 16970
                },
                "b0065": {
                    "endOffset": 16977,
                    "startOffset": 16970
                },
                "b0070": {
                    "endOffset": 16977,
                    "startOffset": 16970
                },
                "b0075": {
                    "endOffset": 16977,
                    "startOffset": 16970
                }
            },
            "secId": "s0005",
            "sentence": "Preclinical trials have suggested immunotherapy to be a promising therapeutic avenue for neurodegenerative diseases associated with proteinopathies, including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Huntington\u2019s Disease (HD), prion diseases, and ALS [12\u201315].",
            "startOffset": 16708,
            "title": "Introduction"
        },
        {
            "endOffset": 22961,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "To rule out potential interference of glycosylation with the immune response profile of tgG-DSE2lim, we also included a cohort vaccinated with PNGase F treated tgG-DSE2lim.",
            "startOffset": 22789,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 16608,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 16607,
                    "startOffset": 16604
                }
            },
            "secId": "s0005",
            "sentence": "Some studies have suggested that mutant SOD1 imparts a neurotoxic gain-of-function linked to the propensity of mutant proteins to misfold and aggregate [7].",
            "startOffset": 16452,
            "title": "Introduction"
        },
        {
            "endOffset": 23794,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "tgG-DSE5b induced antibody response peaked at week 7 and sustained up to week 18, followed by a trend of decline thereafter.",
            "startOffset": 23670,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 32680,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Plates were then washed and incubated with biotinylated goat anti-mouse IgG2c or IgG1 antibody (1:10,000) in blocking buffer for 1 h at RT.",
            "startOffset": 32541,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 29511,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "hSOD1G37R transgenic mice (line 29) on a C57BL/6-congenic background, B6.Cg-Tg(SOD1*G37R)29Dpr/J, were purchased from the Jackson Laboratory (Bar Harbor, ME, USA).",
            "startOffset": 29348,
            "title": "Animals"
        },
        {
            "endOffset": 28887,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "For example, by day 576, the survival rate of tgG-DSE2lim treated hSOD1G37R was 83.3%, in contrast to 37.5% and 58.3% for control and tgG-DSE5b treated hSOD1G37R animals, respectively.",
            "startOffset": 28703,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 23669,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "No significant difference was observed between tgG-DSE2lim and tgG-DSE2lim PNGase F at any time point, both peaking at week 10\u201314 and sustaining till endpoint.",
            "startOffset": 23510,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 30414,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "To express tgG-DSE-His recombinant proteins, HEK293T cells were grown in Dulbecco's Modified Eagle's medium (DMEM) containing 50 \u03bcg/ml Gentamycin and 10% FBS.",
            "startOffset": 30256,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 46542,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0105",
            "sentence": "Finally, our findings imply that the conformation-based disease specific vaccination strategy can also be extended to other types of ALS, such as those associated with TDP-43 proteinopathy that is present in the majority of sALS (\u223c90% of all ALS).",
            "startOffset": 46295,
            "title": "Future direction: development of a multivalent vaccine against SOD1 misfolding"
        },
        {
            "endOffset": 40478,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "Therefore, it is crucial to identify the precise DSEs that distinguish pathogenic from native forms of a self-protein in order to maximize the efficacy of targeting disease-associated conforms while minimizing the potential for deleterious autoimmune complications.",
            "startOffset": 40213,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 31423,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Peak elutions were identified using Bradford aassay, then pooled and dialyzed into phosphate buffered saline (PBS).",
            "startOffset": 31308,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 33793,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "The rotarod was set to begin at 5 rpm, ramping up to 15 rpm over 30 s, then remaining at 15 rpm for 150 s for a total 180 s.",
            "startOffset": 33669,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 22053,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 22052,
                    "startOffset": 22048
                }
            },
            "secId": "s0015",
            "sentence": "Specifically, we established that a truncated rabies glycoprotein, tgG, induced a strong desirable Th2-biased humoral response, as compared to other commonly used carrier proteins such as Leukotoxin (Lkt), which induced a Th1/Th2 balanced response in vaccinated mice [22].",
            "startOffset": 21781,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 29316,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "This suggests that DSE2 may be a key region in SOD1 linked to survival and validates the effectiveness of targeting this region on life expectancy in different immunization approaches.",
            "startOffset": 29132,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 15756,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 15755,
                    "startOffset": 15752
                }
            },
            "secId": "s0005",
            "sentence": "Up to 2017, riluzole had been the only FDA approved drug for treatment of ALS since 1995, but it extends survival by only 2\u20133 months [2].",
            "startOffset": 15619,
            "title": "Introduction"
        },
        {
            "endOffset": 32867,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Plates were then washed, incubated with 1:20,000 diluted streptavidin-AP for 45 min at RT, developed with 1 mg/ml PNPP buffer for 2 h, and finally read at 405 nm with a 490 nm reference.",
            "startOffset": 32681,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 25671,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Serum samples were collected 1 week prior to immunization and at weeks 2, 9 and 18 following the initial immunization.",
            "startOffset": 25553,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in hSOD1G37R animals"
        },
        {
            "endOffset": 27889,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The median age (days) of each cohort in the above clinical analysis is summarized below:",
            "startOffset": 27801,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 30975,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Once reaching a density of 2\u20133 \u00d7 106 cells/ml, cells were collected and resuspended in 100 ml fresh serum free selection media and incubated with constant shaking.",
            "startOffset": 30812,
            "title": "Construction and purification of tgG-DSE immunogens"
        },
        {
            "endOffset": 38530,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 38529,
                    "startOffset": 38525
                }
            },
            "secId": "s0090",
            "sentence": "Based on our experience with a peptide-based vaccine development against prion proteins, we here chose tgG over the more commonly used Leukotoxin or gG as the DSE carrier [22].",
            "startOffset": 38354,
            "title": "The choice of carrier"
        },
        {
            "endOffset": 26903,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Control hSOD1G37R animals were \u223c345 days of age when 30% of the cohort reached HLR2, which was delayed by 70 days in tgG-DSE5b vaccinated group.",
            "startOffset": 26759,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 16245,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 16244,
                    "startOffset": 16239
                },
                "b0020": {
                    "endOffset": 16244,
                    "startOffset": 16239
                },
                "b0025": {
                    "endOffset": 16244,
                    "startOffset": 16239
                }
            },
            "secId": "s0005",
            "sentence": "Natively folded SOD1 exists as a homodimer via an intramolecular disulfide bond, with each monomer binding a copper/zinc ion [3\u20135].",
            "startOffset": 16114,
            "title": "Introduction"
        },
        {
            "endOffset": 26993,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The effect of tgG-DSE5b on disease progression was especially prominent during end stage.",
            "startOffset": 26904,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 28702,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Interestingly, although both vaccines significantly improved the life expectancy of hSOD1G37R animals, tgG-DSE2lim exhibited a far greater protection over tgG-DSE5b during earlier symptomatic stage of disease.",
            "startOffset": 28493,
            "title": "tgG-DSE2lim and tgG-DSE5b extended the life expectancy of hSOD1G37R mice"
        },
        {
            "endOffset": 37596,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "Both strains possessed distinct profiles of structural compositions, i.e., full-length or truncated monomers and larger aggregates.",
            "startOffset": 37465,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 19153,
            "parents": [],
            "secId": "s0005",
            "sentence": "Two DSE-based vaccines against misfolded SOD1, tgG-DSE2lim and tgG-DSE5b, were created and used to immunize a late onset ALS mouse model expressing human mutant SOD1-G37R (hSOD1G37R).",
            "startOffset": 18970,
            "title": "Introduction"
        },
        {
            "endOffset": 24255,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 24254,
                    "startOffset": 24250
                }
            },
            "secId": "s0020",
            "sentence": "The ratio of IgG1/IgG2c titres was used as an indirect measure of Th2/Th1 bias [23].",
            "startOffset": 24171,
            "title": "Immunogenicity of tgG-DSE2lim and tgG-DSE5b in normal C57BL/6 mice"
        },
        {
            "endOffset": 21215,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 21214,
                    "startOffset": 21210
                }
            },
            "secId": "s0015",
            "sentence": "Further optimization for enhanced immunogenicity and vaccine utility was performed using a novel in silico epitope immunogenicity characterization program, EpIC [21].",
            "startOffset": 21049,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 22287,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 22286,
                    "startOffset": 22280
                },
                "b0055": {
                    "endOffset": 22286,
                    "startOffset": 22280
                }
            },
            "secId": "s0015",
            "sentence": "Earlier vaccination studies using recombinant G93A-SOD1 as the immunogen showed that the magnitude of epitope-specific antibody titres was highly correlated with the clinical outcomes of vaccinated mutant SOD1 transgenic mice [9,11].",
            "startOffset": 22054,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 20869,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 20868,
                    "startOffset": 20864
                }
            },
            "secId": "s0015",
            "sentence": "Utilizing \u201ccollective coordinates\u201d, we identified more defined fragments in the above SOD1 regions that were most likely to unfold/misfold under disease conditions, 132EESTKT137 and 35IKGLTEG41 [20].",
            "startOffset": 20670,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 36594,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "In the final plateau phase, misfolded chain substrates of the process are depleted, with no further change in \u03b2-sheets content.",
            "startOffset": 36467,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 33247,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "HLR score and rotarod performance were performed twice prior to week 0 to serve as learning and conditioning, and then once weekly for the rest of the trial until end point.",
            "startOffset": 33074,
            "title": "Clinical assessment"
        },
        {
            "endOffset": 37069,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0085",
            "sentence": "That is, DSE5b may be preferably exposed in misfolded \u201cseeds\u201d, the predominant species of hSOD1G37R during the lag phase, whereas DSE2lim may be favourably accessible in oligomers and/or fibrils, the predominant species during later phases of amyloidogenesis.",
            "startOffset": 36810,
            "title": "DSE2lim and DSE5b may target distinct species of misfolded SOD1 and/or act through different mechanisms"
        },
        {
            "endOffset": 33006,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Titres were calculated as the reciprocal of the highest dilution with a positive reading 2 standard deviations above the negative control.",
            "startOffset": 32868,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 34547,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "The Kruskal-Wallis and Dunn\u2019s multiple comparison tests were performed to identify significant differences in the Th2 /Th1 bias of tgG-DSE2lim \u00b1 PNGase F and tgG-DSE5b induced antibody responses in vaccinated normal C57BL/6 mice.",
            "startOffset": 34318,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 39180,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0090",
            "sentence": "If safe and efficacious, higher antibody production efficiency would obviously be an attractive feature for development of human immunotherapeutics.",
            "startOffset": 39032,
            "title": "The choice of carrier"
        },
        {
            "endOffset": 21048,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0015",
            "sentence": "Notably, we found that a linear peptide mapping to the short \u03b1-helix 32EESTKT13 was the most potent DSE in the ESL, presumably due to unwinding of the \u03b1-helix in SOD1 misfolding.",
            "startOffset": 20870,
            "title": "Designs of DSE2lim and DSE5b based vaccines"
        },
        {
            "endOffset": 27681,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The rotarod performance of control group continued to deteriorate rapidly thereafter, especially for the following 35 days till 541 days of age, which was significantly ameliorated in tgG-DSE5b treated animals (p = 0.01).",
            "startOffset": 27460,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 41668,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0095",
            "sentence": "One plausible explanation is that \u201crec G93A\u201d vaccination induced polyclonal antibodies that targeted not only misfolded SOD1 but also the native conformer.",
            "startOffset": 41513,
            "title": "Comparison of efficacy from the current study with previous vaccination trials using the hSOD1G37R mouse model"
        },
        {
            "endOffset": 43880,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "secId": "s0100",
            "sentence": "This highlights the validity and significance of conformation specificity in the safety and disease-modifying efficacy of the immunotherapeutics against proteinopathies.",
            "startOffset": 43711,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 26381,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "HLR2 and HLR1 were used as a measurement of disease onset and progression, respectively.",
            "startOffset": 26293,
            "title": "tgG-DSE5b significantly delayed disease onset and attenuated disease progression in hSOD1G37R animals"
        },
        {
            "endOffset": 44117,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0250": {
                    "endOffset": 44116,
                    "startOffset": 44112
                }
            },
            "secId": "s0100",
            "sentence": "Moreover, the immune response bias elicited by a vaccine can also have a significant impact on the safety outcome, e.g., the AN1792 trial reported meningoencephalitis in 6% of the patients as a consequence of a Th1 immune response [50].",
            "startOffset": 43881,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 17857,
            "parents": [],
            "secId": "s0005",
            "sentence": "Active immunization for proteinopathies is complicated by tolerance of the immune system to antigens associated with self-proteins.",
            "startOffset": 17726,
            "title": "Introduction"
        },
        {
            "endOffset": 42515,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 42514,
                    "startOffset": 42510
                }
            },
            "secId": "s0100",
            "sentence": "A number of other neurodegenerative diseases share a similar propagating protein misfolding mechanism to ALS, and are characterized with misfolding/aggregation of pathogenic proteins, including amyloid-\u03b2 (A\u03b2) and tau in AD, \u03b1-synuclein in PD and Lewy body dementia, polyQ repeat expansions in HD, and the prion protein in prion diseases [15].",
            "startOffset": 42173,
            "title": "Immunotherapies for other neurodegenerative diseases"
        },
        {
            "endOffset": 32540,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Plates were washed with PBS containing 0.05% Tween-20 (PBST) and blocked with 0.5% gelatin in PBST for 1 h, followed by incubation with serially diluted serum samples for 2 hrs at room temperature (RT).",
            "startOffset": 32338,
            "title": "Antibody isotyping"
        }
    ],
    "docId": "S0264410X19309351",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Beibei",
                "initial": "B.",
                "last": "Zhao"
            },
            {
                "email": null,
                "first": "Kristen",
                "initial": "K.",
                "last": "Marciniuk"
            },
            {
                "email": null,
                "first": "Ebrima",
                "initial": "E.",
                "last": "Gibbs"
            },
            {
                "email": null,
                "first": "Masoud",
                "initial": "M.",
                "last": "Yousefi"
            },
            {
                "email": null,
                "first": "S.",
                "initial": "S.",
                "last": "Napper"
            },
            {
                "email": "neil.cashman@vch.ca",
                "first": "Neil R.",
                "initial": "N.R.",
                "last": "Cashman"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.07.044",
        "firstpage": "4920",
        "issn": "0264410X",
        "lastpage": "4927",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1"
    }
}